Already positive, the research from JP Morgan and its analyst Celine Pannuti still consider the stock as a Buy opportunity. The target price is unchanged at CHF 130.
In a research note, JP Morgan analyst Celine Pannuti has maintained his recommendation on the stock with a Neutral rating. The target price remains unchanged at CHF 2950.
Initially Neutral on the company, JP Morgan s analyst Celine Pannuti maintained his recommendation. The target price is unchanged and still at EUR 175.